SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Disease: European Neurodegeneration Epidemiology

disease 976 words KG: ent-dise-d37f6b77

section:diseases kind:disease topic:alzheimers topic:parkinsons topic:als topic:ftd topic:europe

Contents

European Neurodegeneration Epidemiology

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 1.00 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.97 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.96 Transcriptional Autophagy-Lysosome Coupling
Score: 0.95 CYP46A1 Overexpression Gene Therapy
Score: 0.94

Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.90 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.88 Senescence-Activated NAD+ Depletion Rescue
Score: 0.87 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.86 Digital Twin-Guided Metabolic Reprogramming
Score: 0.86 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.85 Multi-Modal Stress Response Harmonization
Score: 0.84 Competitive APOE4 Domain Stabilization Peptides
Score: 0.84 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.84 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.84 Circadian-Synchronized Proteostasis Enhancement
Score: 0.83 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.83 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.83 Smartphone-Detected Motor Variability Correction
Score: 0.82 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.82 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.82 Senescent Cell Mitochondrial DNA Release
Score: 0.81 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.81 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.81 Blood-Brain Barrier SPM Shuttle System
Score: 0.80 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.80 Circadian Clock-Autophagy Synchronization
Score: 0.80 Adenosine-Astrocyte Metabolic Reset
Score: 0.80 Retinal Vascular Microcirculation Rescue
Score: 0.79 Senescence-Induced Lipid Peroxidation Spreading
Score: 0.79

Related Analyses (30)

TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed

Related Experiments (30)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40

Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40 s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40

See Also (15)

Yoga Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 139 hypotheses Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses

VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses tudca-udca-neurodegeneration
therapeutic · Pages share 139 hypotheses TRPM8 Agonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neuro
therapeutic · Pages share 139 hypotheses TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses Transcranial Magnetic Stimulation Therapy for Neurodege
therapeutic · Pages share 139 hypotheses TLR7/8/9 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses

SciDEX — scidex.ai — Dashboard | Atlas